CA2321105A1 - Proteine de la famille des recepteurs a chaine courte humains du tnf - Google Patents
Proteine de la famille des recepteurs a chaine courte humains du tnf Download PDFInfo
- Publication number
- CA2321105A1 CA2321105A1 CA002321105A CA2321105A CA2321105A1 CA 2321105 A1 CA2321105 A1 CA 2321105A1 CA 002321105 A CA002321105 A CA 002321105A CA 2321105 A CA2321105 A CA 2321105A CA 2321105 A1 CA2321105 A1 CA 2321105A1
- Authority
- CA
- Canada
- Prior art keywords
- sctr
- polynucleotide
- sequence
- seq
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70578—NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
L'invention porte sur une protéine de la famille des récepteurs à chaîne courte humains du TNF (SCTR) et sur des polynucléotides identifiant le SCTR et codant pour lui. L'invention porte également sur des vecteurs d'expression, des cellules hôtes, des agonistes et des antagonistes ainsi que sur des méthodes de traitement ou prévention de troubles associés à l'expression du SCTR.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2480898A | 1998-02-17 | 1998-02-17 | |
US09/024,808 | 1998-02-17 | ||
PCT/US1999/002570 WO1999041374A2 (fr) | 1998-02-17 | 1999-02-05 | Proteine de la famille des recepteurs a chaine courte humains du tnf |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2321105A1 true CA2321105A1 (fr) | 1999-08-19 |
Family
ID=21822505
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002321105A Abandoned CA2321105A1 (fr) | 1998-02-17 | 1999-02-05 | Proteine de la famille des recepteurs a chaine courte humains du tnf |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1054961A2 (fr) |
JP (1) | JP2002503464A (fr) |
AU (1) | AU2589399A (fr) |
CA (1) | CA2321105A1 (fr) |
WO (1) | WO1999041374A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001034800A1 (fr) * | 1999-11-12 | 2001-05-17 | Human Genome Sciences, Inc. | Nouvelles proteines 19 secretees par l'homme |
AU2003247806B2 (en) * | 2002-07-08 | 2009-11-12 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
JP5746191B2 (ja) * | 2009-10-19 | 2015-07-08 | ハナル バイオファーマ カンパニーリミテッドHanAll Biopharma Co., Ltd. | 修飾されたヒト腫瘍壊死因子受容体−1ポリペプチドまたはその断片及びその製造方法 |
CA2782320A1 (fr) | 2009-12-02 | 2011-06-09 | Acceleron Pharma Inc. | Compositions et procedes pour augmenter la demi-vie serique de proteines de fusion fc |
ES2626418T3 (es) * | 2010-12-23 | 2017-07-25 | Hanall Biopharma Co., Ltd. | Polipéptido modificado del receptor-1 del factor de necrosis tumoral humano o fragmento del mismo y procedimiento de preparación del mismo |
WO2012170938A1 (fr) | 2011-06-08 | 2012-12-13 | Acceleron Pharma Inc. | Compositions et procédés pour augmenter la demi-vie sérique |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6369027B1 (en) * | 1995-12-22 | 2002-04-09 | Amgen Inc. | Osteoprotegerin |
WO1997033904A1 (fr) * | 1996-03-12 | 1997-09-18 | Human Genome Sciences, Inc. | Recepteurs contenant un domaine de mort cellulaire |
-
1999
- 1999-02-05 JP JP2000531555A patent/JP2002503464A/ja active Pending
- 1999-02-05 WO PCT/US1999/002570 patent/WO1999041374A2/fr not_active Application Discontinuation
- 1999-02-05 AU AU25893/99A patent/AU2589399A/en not_active Abandoned
- 1999-02-05 EP EP99905816A patent/EP1054961A2/fr not_active Withdrawn
- 1999-02-05 CA CA002321105A patent/CA2321105A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1999041374A3 (fr) | 1999-09-23 |
EP1054961A2 (fr) | 2000-11-29 |
JP2002503464A (ja) | 2002-02-05 |
AU2589399A (en) | 1999-08-30 |
WO1999041374A2 (fr) | 1999-08-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6645499B1 (en) | Human ena/VASP-like protein splice variant | |
WO1999049038A2 (fr) | Proteines de fixation du calcium humaines | |
WO1999029849A1 (fr) | Recepteurs couples a la proteine g associes a une reaction immunitaire | |
US6348576B1 (en) | Human cornichon molecule | |
CA2314884A1 (fr) | Proteines du type facteur humain de necrose tumorale r2 | |
US6589935B1 (en) | Insulin receptor tyrosine kinase substrate | |
EP0970215A1 (fr) | Suppresseur de la signalisation cytokinaire | |
CA2321105A1 (fr) | Proteine de la famille des recepteurs a chaine courte humains du tnf | |
CA2296666A1 (fr) | Proteine de type beta recepteur des cellules t | |
US6503708B1 (en) | Microtubule-associated protein | |
EP1007676A1 (fr) | Proteine ressemblant au recepteur de l'immunoglobuline e de haute affinite | |
WO1999004002A1 (fr) | Matriline-3 humaine | |
WO1998056912A1 (fr) | Proteine liante humaine appelee formine | |
EP1507007A1 (fr) | Protéines liées au cycle cellulaire | |
CA2320427A1 (fr) | Proteines receptrices humaines | |
WO1999011794A2 (fr) | Nouvelle kinase vrk1 | |
WO1998054320A1 (fr) | Proteine de metaxine humaine | |
US6376651B1 (en) | CAF1-related protein | |
US6365714B1 (en) | Translational regulator | |
WO1999037790A1 (fr) | Proteine humaine de calcineurine de type b | |
CA2304126A1 (fr) | Regulateur de la croissance cellulaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |